Rob van Montfort
@robvanmontfort.bsky.social
150 followers 160 following 15 posts
Structural biologist at ICR London focused on cancer drug discovery. Views my own.
Posts Media Videos Starter Packs
robvanmontfort.bsky.social
Thank you for a great day with us @icr.ac.uk and wonderful drug discovery talk @hartungingo.bsky.social!
temt-icr.bsky.social
Great day & night discussing how to design impactful drugs 💊 with @hartungingo.bsky.social!
Thanks for a great talk and lively discussion with @agako7.bsky.social, @robvanmontfort.bsky.social, Zoran Rankovich & the ICR Centre for Protein Degradation! Cheers 🍻!
Five people at a restaurant table, looking in to the camera and smiling.
Reposted by Rob van Montfort
agako7.bsky.social
agako7.bsky.social
🌟🌟🌟 Join our cancer drug discovery team in London-Sutton! 🌟🌟🌟
We’re looking for a passionate biologist eager to drive innovation in targeted protein degradation and cancer drug discovery. If you’re seeking to make a real impact, we would love to hear from you! #CancerResearch #DrugDiscovery
#ICR
ICR Centre for Protein Degradation on LinkedIn: Higher Scientific Officer - Drug Discovery Biology, Centre for Protein…
🤝 Are you passionate about Targeted Protein Degradation and want to join us on our mission to make the discoveries that defeat cancer? Dr Agnieszka…
www.linkedin.com
Reposted by Rob van Montfort
icr.ac.uk
NEWS: NICE has recommended capivasertib for advanced #BreastCancer.

The decision makes the targeted drug available, in combination with fulvestrant, for some NHS patients with the most common type of breast cancer.

Read more about the history of the drug⬇️
www.icr.ac.uk/about-us/icr...
robvanmontfort.bsky.social
Fondly remember Jan for his enthusiasm, rigorous science, and the kind person that he was.
robvanmontfort.bsky.social
The Centre for Cancer Drug Discovery @icr.ac.uk looking fantastic in today's evening sun
Reposted by Rob van Montfort
icr.ac.uk
Today is #InternationalWomensDay 👏

We are incredibly proud to celebrate the women of the ICR who are dedicated, driven, and determined to make a difference.

You inspire us every day 👩‍🔬👩‍💻👩‍💼

#IWD2025 #AccelerateAction
Reposted by Rob van Montfort
titiasixma.bsky.social
Today Jan Drenth would have been 100 years, but sadly he passed away last week.
He was the founding father of structural biology in the Netherlands and his modesty, his gentle humor and his generosity set the spirit for the amazing environment in Groningen where i did my PhD.
Reposted by Rob van Montfort
icr.ac.uk
It's #InternationalMotherLanguageDay 🌍

We're proud of our diverse community who are dedicated to defeating cancer.

Our staff and students from across the globe come from a variety of backgrounds and cultures, and speak different languages, but are united by one mission ♥️
Reposted by Rob van Montfort
icr.ac.uk
📰 Prof Paul Workman, our former CEO, along with his team in our Centre for Cancer Drug Discovery, have made a breakthrough that could lead to new drugs for #chordoma — a rare #BoneCancer that led to the death of his mother.

Read more in @theguardian.com ⤵️

www.theguardian.com/science/2025...
British professor makes ‘thrilling’ breakthrough for cancer that killed his mother
Paul Workman has researched untreatable chordoma for years. Now new technology points towards to a potential drug to beat it
www.theguardian.com
Reposted by Rob van Montfort
scurry.bsky.social
Now over 900 signatures. Please keep signing and sharing to send a clear message to the Royal Society that we want them to stand up for values that we all hold dear: docs.google.com/forms/d/e/1F...
Reposted by Rob van Montfort
icr.ac.uk
On International Day of Women and Girls in Science, we're celebrating our awe-inspiring women helping to defeat cancer 👩‍🔬👏

Hear from Professor Ros Eeles, Professor Helen McNair
(The Royal Marsden NHS) and ICR PhD students Clara, Nivetha, and Anna about what #IDWGS means to them ⬇️

#WomenInScience
Reposted by Rob van Montfort
icr.ac.uk
We’re delighted that The Scottish Medicines Consortium (SMC) has today recommended olaparib for use in advanced #BreastCancer.

The treatment offers the chance of longer, healthier lives for people with breast cancer caused by faulty #BRCA1 or #BRCA2 genes.

scottishmedicines.org.uk/about-us/lat...
February 2025 decisions news release
scottishmedicines.org.uk
Reposted by Rob van Montfort
sjorsscheres.bsky.social
Will these tools further exacerbate biases in the literature: if the opinion of those who write many papers gets fed into their training more than the opinion of those who write sparingly?

Scientists should use their precious time to do good science, not to write many papers...
nature.com
Nature @nature.com · Feb 6
Many scientists who have tried OpenAI's 'deep research' tool are impressed with its ability to write literature reviews or full review papers and even identify gaps in knowledge. But others are less enthusiastic.

https://go.nature.com/4gu9uOo
OpenAI’s ‘deep research’ tool: is it useful for scientists?
The model produces cited, pages-long reports that might be helpful for generating literature reviews.
go.nature.com
Reposted by Rob van Montfort
dereklowe.bsky.social
I’ve unfortunately needed to add more material to my post from yesterday. The re-election of Donald Trump is looking like the biggest act of American self-destruction since the Civil War.

Same link, new title and some updates.
Revised and Extended: What's Happening Inside the NIH and NSF
www.science.org
Reposted by Rob van Montfort
luketaylorld.bsky.social
ICYMI

The Institute of Cancer Research have made amazing inroads in treating advanced prostate cancer with the new NXP800 drug.

So proud to represent the Institute - they embody the ambition and pursuit of pragmatic hope that Sutton, and the whole country, really needs.
Drug breakthrough offers hope for advanced prostate cancer patients
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide.
buff.ly
robvanmontfort.bsky.social
Looking forward to speak at the 2nd Biophysics for Drug Discovery Summit (ter.li/39kb11) about the integrated biophysical approaches used in our BCL6 project. Collaborative drug discovery with Swen Hoelder, @chemb.bsky.social and @temt-icr.bsky.social at @icrlondon.bsky.social.
robvanmontfort.bsky.social
If you are interested in a PhD studentship in chemical biology linked to brain cancer in children, check out the position Gary Newton and myself have available. @icrlondon.bsky.social. www.icr.ac.uk/study-and-ca...
Targeting SRC in G4-Medulloblastoma
OPEN: Targeting SRC in G4-Medulloblastoma
www.icr.ac.uk
Reposted by Rob van Montfort
icr.ac.uk
🆕 We're getting in on the act with an ICR research #StarterPack. Check it out! ⤵️

Let us know if you're a #cancer researcher at the ICR and The Royal Marsden but not in the pack. 💬
#CancerResearch #CanSky #OncSky

go.bsky.app/EGXU5V1